Published in Clin Otolaryngol on December 01, 2009
Regional peak mucosal cooling predicts the perception of nasal patency. Laryngoscope (2013) 1.35
Perceiving nasal patency through mucosal cooling rather than air temperature or nasal resistance. PLoS One (2011) 1.13
Perception of better nasal patency correlates with increased mucosal cooling after surgery for nasal obstruction. Otolaryngol Head Neck Surg (2013) 1.02
Computed nasal resistance compared with patient-reported symptoms in surgically treated nasal airway passages: a preliminary report. Am J Rhinol Allergy (2012) 1.02
Identifying patients who may benefit from inferior turbinate reduction using computer simulations. Laryngoscope (2015) 0.99
Role of virtual surgery in preoperative planning: assessing the individual components of functional nasal airway surgery. Arch Facial Plast Surg (2012) 0.97
Assessment of nasal septoplasty using NOSE and RhinoQoL questionnaires. Eur Arch Otorhinolaryngol (2012) 0.93
Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis: does it confound outcomes assessment? Laryngoscope (2011) 0.90
Awake measures of nasal resistance and upper airway resistance on CPAP during sleep. J Clin Sleep Med (2011) 0.90
Reliability and validity of the Italian nose obstruction symptom evaluation (I-NOSE) scale. Eur Arch Otorhinolaryngol (2013) 0.89
Traditional Chinese Medicine ZHENG Identification Provides a Novel Stratification Approach in Patients with Allergic Rhinitis. Evid Based Complement Alternat Med (2012) 0.86
Subjective nasal fullness and objective congestion. Proc Am Thorac Soc (2011) 0.83
Allergic Rhinitis in Children: A Randomized Clinical Trial Targeted at Symptoms. Indian J Otolaryngol Head Neck Surg (2014) 0.80
Intersession repeatability of acoustic rhinometry measurements in healthy volunteers. Clin Exp Otorhinolaryngol (2012) 0.79
Re: Correlation between subjective and objective evaluation of the nasal airway. Clin Otolaryngol (2010) 0.79
Critical evaluation of different objective techniques of nasal airway assessment: a clinical review. Eur Arch Otorhinolaryngol (2014) 0.79
Systematic Review and Meta-Analysis in Facial Plastic Surgery. Facial Plast Surg Clin North Am (2015) 0.79
Functional Outcome Evaluation of Septorhinoplasty for Nasal Obstruction. Indian J Otolaryngol Head Neck Surg (2015) 0.78
The relationship between nasal resistance to airflow and the airspace minimal cross-sectional area. J Biomech (2016) 0.78
Nasal obstruction and palate-tongue position on sleep-disordered breathing. Clin Exp Otorhinolaryngol (2013) 0.78
Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma. PLoS One (2016) 0.77
Re: Correlation between subjective and objective evaluation of the nasal airway. Clin Otolaryngol (2010) 0.76
Re: Correlation between subjective and objective evaluation of the nasal airway. Clin Otolaryngol (2010) 0.76
Estimates of nasal airflow at the nasal cycle mid-point improve the correlation between objective and subjective measures of nasal patency. Respir Physiol Neurobiol (2017) 0.75
Re: Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol (2011) 0.75
Activity of hypertonic solution with Silver and Potassium Sucrose Octasulfate on nasal symptoms in obstructive rhinopathy with and without rhinosinusitis. Springerplus (2013) 0.75
Re: Correlation between subjective and objective evaluation of the nasal airway. Clin Otolaryngol (2010) 0.75
Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management. World J Methodol (2016) 0.75
Re: Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol (2010) 0.75
Correlation between Objective and Subjective Assessment of Nasal Patency. Iran J Otorhinolaryngol (2016) 0.75
Computational fluid dynamics: a suitable assessment tool for demonstrating the antiobstructive effect of drugs in the therapy of allergic rhinitis. Acta Otorhinolaryngol Ital (2013) 0.75
Evidence and evidence gaps in therapies of nasal obstruction and rhinosinusitis. GMS Curr Top Otorhinolaryngol Head Neck Surg (2016) 0.75
Cross-cultural adaptation and validation of nasal obstruction symptom evaluation questionnaire in Slovenian language. Zdr Varst (2016) 0.75
Azelastine and budesonide (nasal sprays): Effect of combination therapy monitored by acoustic rhinometry and clinical symptom score in the treatment of allergic rhinitis. Allergy Rhinol (Providence) (2014) 0.75
Correlation of Nasal Mucosal Temperature With Subjective Nasal Patency in Healthy Individuals. JAMA Facial Plast Surg (2016) 0.75
Objective assessment of persistent rhinitis in Chinese and its relationship with serum indicators. Eur Arch Otorhinolaryngol (2014) 0.75
New CFD tools to evaluate nasal airflow. Eur Arch Otorhinolaryngol (2017) 0.75
A neural basis for general intelligence. Science (2000) 4.49
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med (1975) 3.36
The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull World Health Organ (1968) 2.96
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull World Health Organ (1969) 2.77
Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan. Bull World Health Organ (1968) 2.71
OMFS: Gender imbalance? Br Dent J (2016) 2.56
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med (1982) 2.39
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. Aliment Pharmacol Ther (2013) 2.26
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. Aliment Pharmacol Ther (2014) 2.22
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
The effect of magnesium sulphate infusion on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anaesthesia. Anaesthesia (2013) 2.06
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84
Transcriptional regulation of the mosquito vitellogenin gene via a blood meal-triggered cascade. Gene (2001) 1.81
Mechanism of repression of methionine biosynthesis in Escherichia coli. I. The role of methionine, s-adenosylmethionine, and methionyl-transfer ribonucleic acid in repression. Mol Gen Genet (1973) 1.73
Isolation and functional analysis of a human 70,000-dalton heat shock protein gene segment. Proc Natl Acad Sci U S A (1985) 1.70
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69
A rapid procedure for DNA sequencing using transposon-promoted deletions in Escherichia coli. Gene (1985) 1.67
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest (2000) 1.66
Analysis of the results obtained in 120 patients with large acoustic neuromas surgically treated via the translabyrinthine-transtentorial approach. J Neurosurg (2001) 1.64
Unreamed interlocking nailing in open fractures of tibia. J Orthop Surg (Hong Kong) (2004) 1.60
Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest (1994) 1.58
The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. Nature (1997) 1.58
Efficient transformation of the yellow fever mosquito Aedes aegypti using the piggyBac transposable element vector pBac[3xP3-EGFP afm]. Insect Biochem Mol Biol (2001) 1.55
Engineering blood meal-activated systemic immunity in the yellow fever mosquito, Aedes aegypti. Proc Natl Acad Sci U S A (2000) 1.53
Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis. Aliment Pharmacol Ther (2012) 1.53
Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis (1994) 1.52
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
Breast clinic referrals: can mastalgia be managed in primary care? Ir J Med Sci (2014) 1.51
Lymphocytes binding and T cell mitogenic properties of group A streptococcal lipoteichoic acid. J Immunol (1979) 1.49
Should we consent for bowel evisceration as a potential complication of hysterectomy? J Obstet Gynaecol (2008) 1.47
Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene (2007) 1.46
Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. J Clin Invest (1976) 1.46
Surgery of the external nasal valve: the correlation between subjective and objective measurements. Clin Otolaryngol (2014) 1.44
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. J Immunol (1979) 1.43
The gamma and epsilon subunits of the CD3 complex inhibit pre-Golgi degradation of newly synthesized T cell antigen receptors. J Cell Biol (1990) 1.42
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs non-dialyzed patients. J Pak Med Assoc (1994) 1.40
Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J (1999) 1.40
High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia (2007) 1.39
Specific murine B-cell activation by synthetic single-and double-stranded polynucleotides. J Exp Med (1973) 1.37
Bacterial complications of primary varicella in children. Clin Infect Dis (1996) 1.35
Cholera toxoid boosts serum Escherichia coli antitoxin in humans. Infect Immun (1974) 1.35
Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization. J Exp Med (1974) 1.35
Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology (2000) 1.35
The perception and practice of traditional medicine in the treatment of cancers and inflammations by the Hausa and Fulani tribes of Northern Nigeria. J Ethnopharmacol (2007) 1.34
The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema. Br J Dermatol (2013) 1.34
The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. J Infect Dis (1970) 1.34
Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation. Bull World Health Organ (1973) 1.31
Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens. Clin Exp Immunol (1975) 1.31
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer (1984) 1.31
Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines. J Exp Med (1973) 1.30
Use of microculture plates and the multiple automated sample harvester for in vitro microassay of bacterial toxins. Appl Microbiol (1974) 1.30
Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol (1994) 1.29
Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation. J Immunol (1980) 1.29
Partial trisomy 14q-- and pseudoxanthoma elasticum. Clin Genet (1973) 1.27
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med (2011) 1.26
Distinct B cell subpopulations differ in their genetic requirements for activation by T helper cells. Immunol Rev (1982) 1.26
Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet (2005) 1.24
Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study. Br J Cancer (2001) 1.23
Plasma and spinal-fluid blocking factor in SSPE. N Engl J Med (1973) 1.23
Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors (1996) 1.21
Helium-neon laser treatment transforms fibroblasts into myofibroblasts. Am J Pathol (1990) 1.21
Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod (1994) 1.20
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol (2000) 1.19
Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics (1998) 1.18
Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan. Int J Tuberc Lung Dis (2011) 1.18
How far investigations for occult metastases in breast cancer aid the clinician. Clin Oncol (R Coll Radiol) (1991) 1.17
Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. J Clin Invest (1975) 1.16
Molecular typing of methicillin-resistant Staphylococcus aureus strains by PCR-RFLP of SPA gene: a reference laboratory perspective. Indian J Med Microbiol (2009) 1.15
Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest (1998) 1.15
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther (2014) 1.14
Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen. Proc Natl Acad Sci U S A (1981) 1.13
Identification of two forms of an endogenous murine retroviral env gene linked to the Rmcf locus. J Virol (1987) 1.13
T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann N Y Acad Sci (1979) 1.12
Problems in breast pathology. Major Probl Pathol (1979) 1.12
Mutants of Escherichia coli defective in the degradation of guanosine 5'-triphosphate, 3'-diphosphate (pppGpp). Mol Gen Genet (1979) 1.12
Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant (2009) 1.11
Response of CBA/N x DBA2/F1 mice to Nocardia asteroides. Infect Immun (1982) 1.11
Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment. Ann Oncol (2003) 1.10
Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect. J Immunol (1976) 1.10
Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites. J Immunol (1978) 1.10
Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med (1999) 1.10
Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest (1998) 1.10
Control of fetal lung development in the rabbit. Arch Dis Child (1973) 1.10
A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med (2000) 1.09
Contribution of Lyb 5+ and Lyb 5- B cells to the primary and secondary phosphocholine-specific antibody response. J Immunol (1983) 1.09
Report of the 1966-67 cholera vaccine trial in rural East Pakistan. Bull World Health Organ (1972) 1.08